As of 11:53am ET
| -0.78 / -1.53%|
The 1 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 72.00, with a high estimate of 72.00 and a low estimate of 72.00. The median estimate represents a +44.42% increase from the last price of 49.86.
The current consensus among 1 polled investment analysts is to Buy stock in Biospecifics Technologies Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.